SCHEMBL8202022

SCHEMBL8202022

C=C(C)OC(=O)NCc1ccc(CO)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.45
TSHR P16473 2/20 0.41
KMT2A Q03164 2/20 0.41
FAAH O00519 2/20 0.40
HDAC1 Q13547 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 2/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NHERF1 O14745 1/20 0.37
MEN1 O00255 1/20 0.37
RECQL P46063 1/20 0.37
APEX1 P27695 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22281955 0.85 ALDH1A1 (0.50) KMT2AALDH1A1GAAHPGDSMN1; SMN2
SCHEMBL13542055 0.84 KMT2A (0.63) EPHX2KMT2AALDH1A1POLBHPGD
SCHEMBL1951513 0.76 KMT2A (0.66) EPHX2KMT2AHDAC1HDAC6RAB9A
SCHEMBL1164796 0.75 L3MBTL1 (0.56) EPHX2HDAC1HDAC6MAPTGAA
SCHEMBL21648724 0.73 EPHX2 (0.51) EPHX2HDAC1HDAC6ALDH1A1LMNA
SCHEMBL3710489 0.72 HDAC1 (0.49) EPHX2TSHRKMT2AHDAC1RAB9A
SCHEMBL991807 0.72 CASP1 (0.53) EPHX2TSHRKMT2AHDAC1HDAC6
SCHEMBL7252186 0.72 TSHR (0.69) TSHRKMT2AHDAC1RAB9ANPC1
SCHEMBL15738567 0.71 FAAH (0.53) FAAH
SCHEMBL3457884 0.70 TSHR (0.57) EPHX2TSHRKMT2AHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317678-A1 HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE CHROMA THERAPEUTICS LTD. (GB) 2010-12-16 US disclosed
WO-2008053131-A1 HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE CHROMA THERAPEUTICS LTD. (GB) 2008-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317678-A1 HYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE H1-2, HDAC1, H1-0 EPHX2 1138/4885TSHR 2043/4885KMT2A 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.